[1]
|
Anka, A.U., Tahir, M.I., Abubakar, S.D., et al. (2021) Coronavirus Disease 2019 (COVID-19): An Overview of the Immunopathology, Serological Diagnosis and Management. Scandinavian Journal of Immunology, 93, e12998. https://doi.org/10.1111/sji.12998
|
[2]
|
Ong, D., Fragkou, P.C., Schweitzer, V.A., Chemaly, R.F., Moschopoulos, C.D. and Skevaki, C. (2021) How to Interpret and Use COVID-19 Serology and Immunology Tests. Clinical Microbiology and Infection, 27, 981-986. https://doi.org/10.1016/j.cmi.2021.05.001
|
[3]
|
Rai, P., Kumar, B.K., Deekshit, V.K., et al. (2021) Detection Technologies and Recent Developments in the Diagnosis of COVID-19 Infection. Applied Microbiology and Biotechnology, 105, 441-455. https://doi.org/10.1007/s00253-020-11061-5
|
[4]
|
Keyt, B.A., Baliga, R., Sinclair, A.M., et al. (2020) Structure, Function, and Therapeutic Use of IgM Antibodies. Antibodies, 9, Article 53. https://doi.org/10.3390/antib9040053
|
[5]
|
Shi, A.C. and Ren, P. (2021) SARS-CoV-2 Serology Testing: Progress and Challenges. Journal of Immunological Methods, 494, Article 113060. https://doi.org/10.1016/j.jim.2021.113060
|
[6]
|
Wu, F., Zhao, S., Yu, B., et al. (2020) A New Coronavirus Associated with Human Respiratory Disease in China. Nature, 579, 265-269. https://doi.org/10.1038/s41586-020-2008-3
|
[7]
|
Du, Y., Tu, L., Zhu, P., et al. (2020) Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. American Journal of Respiratory and Critical Care Medicine, 201, 1372-1379. https://doi.org/10.1164/rccm.202003-0543OC
|
[8]
|
Cao, X. (2020) COVID-19: Immunopathology and Its Implications for Therapy. Nature Reviews Immunology, 20, 269-270. https://doi.org/10.1038/s41577-020-0308-3
|
[9]
|
Qin, C., Zhou, L., Hu, Z., et al. (2020) Dysregulation of Immune Response in Patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases, 71, 762-768. https://doi.org/10.1093/cid/ciaa248
|
[10]
|
Wang, D., Hu, B., Hu, C., et al. (2020) Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. The Journal of the American Medical Association, 323, 1061-1069. https://doi.org/10.1001/jama.2020.1585
|
[11]
|
Lindsley, A.W., Schwartz, J.T. and Rothenberg, M.E. (2020) Eosinophil Responses during COVID-19 Infections and Coronavirus Vaccination. Journal of Allergy and Clinical Immunology, 146, 1-7. https://doi.org/10.1016/j.jaci.2020.04.021
|
[12]
|
Tabachnikova, A. and Chen, S.T. (2020) Roles for Eosinophils and Basophils in COVID-19? Nature Reviews Immunology, 20, Article 461. https://doi.org/10.1038/s41577-020-0379-1
|
[13]
|
Merad, M. and Martin, J.C. (2020) Author Correction: Pathological Inflammation in Patients with COVID-19: A Key Role for Monocytes and Macrophages. Nature Reviews Immunology, 20, Article 448. https://doi.org/10.1038/s41577-020-0353-y
|
[14]
|
Ramachandran, P., Dobie, R., Wilson-Kanamori, J.R., et al. (2019) Resolving the Fibrotic Niche of Human Liver Cirrhosis at Single-Cell Level. Nature, 75, 512-518. https://doi.org/10.1038/s41586-019-1631-3
|
[15]
|
Winkler, F. and Bengsch, B. (2019) Use of Mass Cytometry to Profile Human T Cell Exhaustion. Frontiers in Immunology, 10, Article 3039. https://doi.org/10.3389/fimmu.2019.03039
|
[16]
|
Chiappelli, F., Khakshooy, A. and Greenberg, G. (2020) COVID-19 Immunopathology and Immunotherapy. Biomedical informatics, 16, 219-222. https://doi.org/10.6026/97320630016219
|
[17]
|
Mclane, L.M., Abdel-Hakeem, M.S. and Wherry, E.J. (2019) CD8 T Cell Exhaustion during Chronic Viral Infection and Cancer. Annual Review of Immunology, 37, 457-495. https://doi.org/10.1146/annurev-immunol-041015-055318
|
[18]
|
Ioannidis, J.P., Fanelli, D., Dunne, D.D., et al. (2015) Meta-Research: Evaluation and Improvement of Research Methods and Practices. PLOS BIOLOGY, 13, e1002264. https://doi.org/10.1371/journal.pbio.1002264
|
[19]
|
Chiappelli, F., Balenton, N. and Khakshooy, A. (2018) Future Innovations in Viral Immune Surveillance: A Novel Place for Bioinformation and Artificial Intelligence in the Administration of Health Care. Biomedical Informatics, 14, 201-205. https://doi.org/10.6026/97320630014201
|
[20]
|
Kasakovski, D., Xu, L. and Li, Y. (2018) T Cell Senescence and CAR-T Cell Exhaustion in Hematological Malignancies. Journal of Hematology & Oncology, 11, Article No. 91. https://doi.org/10.1186/s13045-018-0629-x
|
[21]
|
Huang, C., Wang, Y., Li, X., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
|
[22]
|
Tan, M., Liu, Y., Zhou, R., et al. (2020) Immunopathological Characteristics of Coronavirus Disease 2019 Cases in Guangzhou, China. Immunology, 160, 261-268. https://doi.org/10.1111/imm.13223
|
[23]
|
Diao, B., Wang, C., Tan, Y., et al. (2020) Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19). Frontiers in Immunology, 11, Article 827. https://doi.org/10.3389/fimmu.2020.00827
|
[24]
|
Wan, S., Xiang, Y., Fang, W., et al. (2020) Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing. Journal of Medical Virology, 92, 797-806. https://doi.org/10.1002/jmv.25783
|
[25]
|
Kamphuis, E., Junt, T., Waibler, Z., et al. (2006) Type I Interferons Directly Regulate Lymphocyte Recirculation and Cause Transient Blood Lymphopenia. Blood, 108, 3253-3261. https://doi.org/10.1182/blood-2006-06-027599
|
[26]
|
Shiow, L.R., Rosen, D.B., Brdicková, N., et al. (2006) CD69 Acts Downstream of Interferon-Alpha/Beta to Inhibit S1P1 and Lymphocyte Egress from Lymphoid Organs. Nature, 440, 540-544. https://doi.org/10.1038/nature04606
|
[27]
|
Haveri, A., Smura, T., Kuivanen, S., et al. (2020) Serological and Molecular Findings during SARS-CoV-2 Infection: The First Case Study in Finland, January to February 2020. Eurosurveillance, 25, Article 2000266. https://doi.org/10.2807/1560-7917.ES.2020.25.11.2000266
|
[28]
|
Lou, B., Li, T.D., Zheng, S.F., et al. (2020) Serology Characteristics of SARS-CoV-2 Infection after Exposure and Post-Symptom Onset. The European Respiratory Journal, 56, Article 2000763. https://doi.org/10.1183/13993003.00763-2020
|
[29]
|
Wu, Y.C., Chen, C.S. and Chan, Y.J. (2020) The Outbreak of COVID-19: An overview. Journal of the Chinese Medical Association, 83, 217-220. https://doi.org/10.1097/JCMA.0000000000000270
|
[30]
|
Thevarajan, I., Nguyen, T., Koutsakos, M., et al. (2020) Breadth of Concomitant Immune Responses Prior to Patient Recovery: A Case Report of Non-Severe COVID-19. Nature Medicine, 26, 453-455. https://doi.org/10.1038/s41591-020-0819-2
|
[31]
|
Guo, C., Li, B., Ma, H., et al. (2020) Single-Cell Analysis of Two Severe COVID-19 Patients Reveals a Monocyte-Associated and Tocilizumab-Responding Cytokine Storm. Nature Communications, 11, Article No. 3924. https://doi.org/10.1038/s41467-020-17834-w
|
[32]
|
Ju, B., Zhang, Q., Ge, J., et al. (2020) Human Neutralizing Antibodies Elicited by SARS-CoV-2 Infection. Nature, 584, 115-119. https://doi.org/10.1038/s41586-020-2380-z
|
[33]
|
Tay, M.Z., Poh, C.M., Rénia, L., et al. (2020) The Trinity of COVID-19: Immunity, Inflammation and Intervention. Nature Reviews Immunology, 20, 363-374. https://doi.org/10.1038/s41577-020-0311-8
|